Payment overview · 2025
General Payments
$115.62
3 reported records · 1 companies
Healthcare provider profile · identity verified
Rodney T. Rubi, MD
Allopathic & Osteopathic Physicians|Internal Medicine · ELLINGTON, MO · NPI 1184727422
Verified facts
What the public records show
CMS Open Payments records show Rodney T. Rubi, MD received $115.62 in general payments during 2025 across 3 reported records.
Lundbeck LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lundbeck LLC | Unresolved — no canonical attribution shown | $115.62 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $115.62 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $115.62 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 37 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
37 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 594 | 114 |
| Levothyroxine Sodium | Levothyroxine Sodium | 474 | 68 |
| Gabapentin | Gabapentin | 464 | 73 |
| Omeprazole | Omeprazole | 394 | 65 |
| Amlodipine Besylate | Amlodipine Besylate | 380 | 62 |
| Potassium Chloride | Potassium Chloride | 368 | 60 |
| Lisinopril | Lisinopril | 344 | 63 |
| Furosemide | Furosemide | 342 | 58 |
| Pantoprazole Sodium | Pantoprazole Sodium | 338 | 62 |
| Eliquis | Apixaban | 323 | 36 |
| Trazodone Hcl | Trazodone Hcl | 304 | 45 |
| Metformin Hcl | Metformin Hcl | 287 | 50 |
| Montelukast Sodium | Montelukast Sodium | 269 | 46 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 260 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 244 | 43 |
| Fluticasone Propionate | Fluticasone Propionate | 238 | 55 |
| Losartan Potassium | Losartan Potassium | 238 | 38 |
| Tamsulosin Hcl | Tamsulosin Hcl | 236 | 43 |
| Quetiapine Fumarate | Quetiapine Fumarate | 225 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 205 | 36 |
| Buspirone Hcl | Buspirone Hcl | 203 | 32 |
| Tizanidine Hcl | Tizanidine Hcl | 203 | 33 |
| Metoprolol Succinate | Metoprolol Succinate | 195 | 40 |
| Meloxicam | Meloxicam | 189 | 34 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 180 | 36 |
| Alprazolam | Alprazolam | 176 | 31 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 175 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 174 | 25 |
| Risperidone | Risperidone | 159 | 17 |
| Sertraline Hcl | Sertraline Hcl | 153 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 151 | 25 |
| Famotidine | Famotidine | 151 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 141 | 42 |
| Ropinirole Hcl | Ropinirole Hcl | 140 | 22 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 139 | 16 |
| Tramadol Hcl | Tramadol Hcl | 139 | 29 |
| Simvastatin | Simvastatin | 138 | 21 |
| Hydrochlorothiazide | Hydrochlorothiazide | 135 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 127 | 18 |
| Januvia | Sitagliptin Phosphate | 126 | 11 |
| Allopurinol | Allopurinol | 123 | 23 |
| Baclofen | Baclofen | 108 | 18 |
| Donepezil Hcl | Donepezil Hcl | 106 | 19 |
| Lamotrigine | Lamotrigine | 105 | 15 |
| Divalproex Sodium | Divalproex Sodium | 103 | 15 |
| Pregabalin | Pregabalin | 101 | 16 |
| Ventolin Hfa | Albuterol Sulfate | 101 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 95 | 15 |
| Jardiance | Empagliflozin | 95 | 15 |
| Lorazepam | Lorazepam | 93 | 13 |
| Topiramate | Topiramate | 93 | suppressed |
| Clonazepam | Clonazepam | 86 | 12 |
| Ozempic | Semaglutide | 86 | 13 |
| Metformin Hcl Er | Metformin Hcl | 85 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 80 | 19 |
| Finasteride | Finasteride | 80 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 74 | 58 |
| Mirtazapine | Mirtazapine | 74 | 16 |
| Clonidine Hcl | Clonidine Hcl | 71 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 71 | 12 |
| Carvedilol | Carvedilol | 70 | 15 |
| Myrbetriq | Mirabegron | 64 | suppressed |
| Xarelto | Rivaroxaban | 63 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 62 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 61 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 61 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 59 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 59 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 58 | 11 |
| Memantine Hcl | Memantine Hcl | 58 | suppressed |
| Prednisone | Prednisone | 58 | 27 |
| Tradjenta | Linagliptin | 58 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 55 | 11 |
| Levetiracetam | Levetiracetam | 54 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 54 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 54 | 11 |
| Glimepiride | Glimepiride | 52 | 12 |
| Olanzapine | Olanzapine | 52 | suppressed |
| Lovastatin | Lovastatin | 51 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 51 | suppressed |
| Aripiprazole | Aripiprazole | 50 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 49 | suppressed |
| Estradiol | Estradiol | 47 | suppressed |
| Glipizide | Glipizide | 46 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 44 | suppressed |
| Ibuprofen | Ibuprofen | 42 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 42 | 11 |
| Naproxen | Naproxen | 42 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 41 | 31 |
| Atenolol | Atenolol | 41 | suppressed |
| Humalog | Insulin Lispro | 41 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 40 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 40 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 38 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 38 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Nystatin | Nystatin | 38 | 21 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 37 | suppressed |
| Rexulti | Brexpiprazole | 37 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 36 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 36 | suppressed |
| Haloperidol | Haloperidol | 35 | suppressed |
| Insulin Lispro | Insulin Lispro | 35 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 34 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 34 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 34 | suppressed |
| Primidone | Primidone | 34 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 34 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 33 | suppressed |
| Spironolactone | Spironolactone | 33 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 32 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 32 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 31 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 31 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 30 | suppressed |
| Trulicity | Dulaglutide | 30 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | suppressed |
| Cefdinir | Cefdinir | 28 | 25 |
| Nystop | Nystatin | 28 | 19 |
| Ketoconazole | Ketoconazole | 27 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 27 | 11 |
| Asa-Butalb-Caffeine-Codeine | Codeine/Butalbital/Asa/Caffein | 26 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | 14 |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 26 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Azithromycin | Azithromycin | 24 | 20 |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Lacosamide | Lacosamide | 24 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 24 | suppressed |
| Bupropion Xl | Bupropion Hcl | 23 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 17 |
| Vascepa | Icosapent Ethyl | 23 | suppressed |
| Celecoxib | Celecoxib | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 15 |
| Incruse Ellipta | Umeclidinium Bromide | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 17 |
| Techlite Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 20 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 20 | suppressed |
| Novolog | Insulin Aspart | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 19 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Synthroid | Levothyroxine Sodium | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 18 | 11 |
| Colchicine | Colchicine | 18 | suppressed |
| Ranolazine Er | Ranolazine | 18 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 17 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Cilostazol | Cilostazol | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Clotrimazole | Clotrimazole | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 12 |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | 13 |
| Erythromycin | Erythromycin Base | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 13 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | 11 |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 13 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Xtampza Er | Oxycodone Myristate | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 11 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $115.62 · 3 records | Lundbeck LLC | REXULTI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lundbeck LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error